Gapping down
In reaction to earnings/guidance:
- CONN -5.7%, PLAB -1.4%
Other news:
- SGMO -3.8% (Updated Preliminary Phase 1/2 Data in Fabry Disease Clinical Study Showing Continued Tolerability and Sustained Elevated a-gal A Enzyme Activity in Five Longest Treated Patients)
- AX -2% (files to delay 10-K due to required testing and validation of Axos Advisor Services activity having taken longer than anticipated)
- LCID -1.4% (files for $8 bln mixed securities shelf offering; also stock offering related to warrants)
Analyst comments:
- MOLN -5.8% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
- GCO -0.7% (downgraded to Neutral from Buy at Seaport Research Partners)